Vanmorgen heeft prof. dr. Willy Spaan, voorzitter van de Nederlandse Federatie van Universitair Medische Centra (NFU) het plan ‘Onderzoek & Innovatie met en voor de gezonde regio’ overhandigd aan minister Bruins (Medische zorg). Het plan schetst een verbindende rol van de universitair medische centra (umc’s) in het oplossen van gezondheidsvraagstukken dicht bij huis.
New medical technology is essential for early recognition, better monitoring and faster treatment of cardiovascular disease. For this reason, the Dutch CardioVascular Aliance, and the Innovative Medical Devices Initiative (IMDI) launched their new funding programme.
Australian product innovation agency IDE Group recently opened its new European headquarters in Rotterdam, from where it will serve its European partners. IDE Group develops medical technology innovations in partnership with life sciences companies and technical universities.
Top Sector Life Sciences & Health (LSH) supports innovative research and development realised by public-private partnerships (PPP). The Top Sector brings together stakeholders in a shared, consolidated innovation infrastructure. By means of PPP Allowance, the Top Sector provides a financial instrument to help consortia consisting of research organisations, knowledge institutes, companies, and health foundations to realise their innovative ideas.
Dutch biotechnology company Micreos announced it has secured €30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin XZ.700 and the USA launch of its breakthrough OTC Gladskin product for eczema.
During the EMA symposium of the Dutch Association of Pharmaceutical Medicine (NVFG) on February 5 in Amsterdam, the Dutch State Secretary of Economic Affairs and Climate Policy, Mona Keijzer, announced the launch of the ‘National Action Programme European Medicines Agency', which will ensure the Netherlands gains optimal results from the recent arrival of the EMA.
The 26th of March marks the start of four scientific projects that will investigate the effects of nutrition on the fitness of the immune system. The scientists received funding for these projects from the Partnership programme of NWO Domain Applied and Engineering Sciences and Danone Nutricia Research. NWO and Danone Nutricia Research are investing a total of 3 million Euros in this programme.
Loopt jouw organisatie tegen uitdagingen aan in de ontwikkeling of toepassing van diervrije innovaties? Reageer dan voor 23 april op de Create2Solve-oproep van het ZonMw programma Meer Kennis met Minder Dieren. Dien je “Challenge” in en wie weet broeden onderzoeksinstellingen en MKB straks op jouw innovatieve, diervrije oplossing.
ProQR Therapeutics, a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, announced the strategic spin out of the Dystrophic Epidermolysis Bullosa (DEB) activities into the newly formed company, Wings Therapeutics.
Pacmed en Amsterdam UMC hebben een langdurige samenwerkingsovereenkomst getekend. Het doel is om samen de zorg voor patiënten op de Intensive Care (IC) te blijven verbeteren met behulp van big data en machine learning.